Table 2.
All surveyed patients (n = 820) | Medical and elderly wards |
Critical care wards |
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All surveyed patients (n = 698) |
SARSCoV-2 positive (n = 421) |
SARSCoV-2 negative (n = 277) |
All surveyed patients (n = 122) |
SARSCoV-2 positive (n = 110) |
SARSCoV-2 negative (n = 12) |
||||||||||||||||
Total surveyed patients | Total surveyed patients with characteristic | % | Total surveyed patients | Total surveyed patients with characteristic | % | Total surveyed patients | Total surveyed patients with characteristic | % | Total surveyed patients | Total surveyed patients with characteristic | % | Total surveyed patients | Total surveyed patients with characteristic | % | Total surveyed patients | Total surveyed patients with characteristic | % | Total surveyed patients | Total surveyed patients with characteristic | % | |
Antibiotic(s) on admission | 789 | 492 | 62.4 | 672 | 409 | 60.9 | 402 | 257 | 63.9 | 270 | 152 | 56.3 | 122 | 83 | 68.0 | 105 | 79 | 75.2 | 12 | 4 | 33.3 |
Empirical antibiotic(s) on admission | 403 | 389 | 96.5 | 327 | 315 | 96.3 | 230 | 219 | 95.2 | 97 | 96 | 99.0 | 76 | 74 | 97.4 | 73 | 71 | 97.3 | 3 | 3 | 100.0 |
IV antibiotic(s) on admission | 461 | 276 | 59.9 | 384 | 212 | 55.2 | 243 | 126 | 51.9 | 141 | 86 | 61.0 | 77 | 64 | 83.1 | 73 | 60 | 82.2 | 4 | 4 | 100.0 |
Antibiotic(s) on day of survey | 818 | 368 | 45.0 | 697 | 314 | 45.1 | 421 | 153 | 36.3 | 276 | 161 | 58.3 | 121 | 54 | 44.6 | 109 | 50 | 45.9 | 12 | 4 | 33.3 |
Empirical antibiotic(s) on day of survey | 367 | 320 | 87.2 | 313 | 281 | 89.8 | 153 | 133 | 86.9 | 160 | 148 | 92.5 | 54 | 39 | 72.2 | 50 | 35 | 70.0 | 4 | 4 | 100.0 |
IV antibiotic(s) on day of survey | 364 | 178 | 48.9 | 312 | 129 | 41.3 | 152 | 60 | 39.5 | 160 | 69 | 43.1 | 52 | 49 | 94.2 | 48 | 45 | 93.8 | 4 | 4 | 100.0 |
Systemic antifungal on day of survey | 818 | 13 | 1.6 | 672 | 1 | 0.1 | 402 | 1 | 0.2 | 270 | 0 | 0.0 | 122 | 12 | 9.8 | 105 | 12 | 11.4 | 12 | 0 | 0.0 |
Empirical systemic antifungal on day of survey | 13 | 5 | 38.5 | 1 | 0 | 0.0 | 1 | 0 | 0.0 | 0 | 0 | – | 12 | 5 | 41.7 | 12 | 5 | 41.7 | 0 | 0 | – |